DOSE OF REALITY: BIG PHARMA’S EGREGIOUS PRICING PRACTICES AND ANTI-COMPETITIVE TACTICS DRIVE HIGHER HEALTH CARE COSTS

01-30-2024 Blog Posts

Big Pharma Price Hikes, Rising Launch Prices And Patent Abuse Impose Massive Costs on Patients, Taxpayers, and the U.S. Health Care System Tomorrow, the U.S. House Committee on Energy and Commerce Health Subcommittee is scheduled to hold a hearing to discuss health care spending in the United States. Ahead of the hearing on this important topic, get […]

BIG PHARMA WATCH: AARP REPORT SHINES LIGHT ON SCALE AND COST OF BIG PHARMA’S PRICE HIKES THAT EXCEED INFLATION

01-19-2024 Blog Posts

Rx Price Watch Analysis Finds Big Pharma Price Increases Outpaced Inflation Every Year Except One Between 2006 and 2020 A new report from AARP finds Big Pharma “consistently” increased prices above the rate of inflation between 2006 and 2020. In fact, the report found that Big Pharma increased prices on 943 blockbuster drugs widely used […]

BIG PHARMA WATCH: BIG PHARMA DELAYS NEW DRUGS THAT COULD HELP PATIENTS TO BOOST PROFITS

01-8-2024 Blog Posts

Report Finds Several Brand Name Drug Companies Waiting to Introduce New Products Until They Can Get Approval for More Lucrative Disease Classes  It appears egregious price hikes on existing prescription drugs, out-of-control prices on new products and anti-competitive schemes to extend monopolies just aren’t enough to satisfy Big Pharma’s appetite for putting profits over patients. […]

DOSE OF REALITY: BIG PHARMA’S R&D INVESTMENTS DISCREDIT DOOM AND GLOOM INNOVATION RHETORIC

01-5-2024 Blog Posts

Report Finds Big Pharma Increased Spending on R&D in First Half of 2023, Made R&D Investment Decisions Without Considering Impact of 2022 Drug Pricing Solutions A recent analysis from research firm ATI Advisory shows that in the first half of 2023, Big Pharma’s research and development (R&D) investment decisions were not impacted by drug pricing […]

DOSE OF REALITY: BREAKING DOWN BIG PHARMA’S YEAR OF BAD BEHAVIOR IN 2023: PART V: BIG PHARMA’S DEBUNKED INNOVATION RHETORIC

01-1-2024 Blog Posts

Big Pharma Discredited Its Own Bogus Rhetoric on Research and Development in 2023 With each new year comes a time-honored tradition for Big Pharma: Hiking prices on hundreds of brand name prescription drugs in the first two weeks of January. As Big Pharma’s next round of January price hikes approach, we can take a look […]

DOSE OF REALITY: BREAKING DOWN BIG PHARMA’S YEAR OF BAD BEHAVIOR IN 2023: PART IV: TAX AVOIDANCE SCHEMES AND KICKBACKS

12-29-2023 Blog Posts

Big Pharma’s Tax Avoidance Schemes and Use of Kickbacks to Boost Profits Came Under Fire in 2023 With each new year comes a time-honored tradition for Big Pharma: Hiking prices on hundreds of brand name prescription drugs in the first two weeks of January. As Big Pharma’s next round of January price hikes approach, we […]

DOSE OF REALITY: BREAKING DOWN BIG PHARMA’S YEAR OF BAD BEHAVIOR IN 2023: PART III: BIG PHARMA’S ANTI-COMPETITIVE TACTICS

12-28-2023 Blog Posts

Exploring the Cost of Big Pharma’s Egregious Abuse of the Patent System With each new year comes a time-honored tradition for Big Pharma: Hiking prices on hundreds of brand name prescription drugs in the first two weeks of January. As Big Pharma’s next round of January price hikes approach, we can take a look back […]

DOSE OF REALITY: BREAKING DOWN BIG PHARMA’S YEAR OF BAD BEHAVIOR IN 2023: PART II: BIG PHARMA’S BIG BLAME GAME, DTC, AND M&A SPENDING

12-27-2023 Blog Posts

Big Pharma’s Year of Big Spending Attempting to Evade Responsibility for High Prices and Advertise High-Priced Brand Name Products With each new year comes a time-honored tradition for Big Pharma: Hiking prices on hundreds of brand name prescription drugs in the first two weeks of January. As Big Pharma’s next round of January price hikes […]

DOSE OF REALITY: BREAKING DOWN BIG PHARMA’S YEAR OF BAD BEHAVIOR IN 2023: PART I: BIG PHARMA’S EGREGIOUS PRICING PRACTICES

12-26-2023 Blog Posts

Take a Look Back on Big Pharma’s Year of Price Hikes And Skyrocketing Launch Prices With each new year comes a time-honored tradition for Big Pharma: Hiking prices on hundreds of brand name prescription drugs in the first two weeks of January. As Big Pharma’s next round of January price hikes approach, we can take […]

DOSE OF REALITY: EXPERT WITNESS HIGHLIGHTS BIG PHARMA’S EGREGIOUS PRICING OF NEW WEIGHT LOSS DRUGS

12-19-2023 Blog Posts

Senate Testimony Underscores Staggering Potential Cost of High-Priced Weight Loss Products for Consumers and U.S. Health Care System During a hearing last Thursday in the U.S. Senate Committee on Health, Education, Labor & Pensions (HELP) titled, “What is Fueling the Diabetes Epidemic?,” expert witness Kasia Lipska, M.D., M.H.S, Associate Professor of Medicine at the Yale […]

Sign-up for updates

  • This field is for validation purposes and should be left unchanged.